LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital Group Dividend Value ETF
CGDV
|
+$486M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$472M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$468M |
| 4 |
THRO
iShares U.S. Thematic Rotation Active ETF
THRO
|
+$457M |
| 5 |
iShares Core International Aggregate Bond Fund
IAGG
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$728M |
| 2 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$336M |
| 3 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$93.5M |
| 4 |
Invesco Preferred ETF
PGX
|
+$91.8M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$82.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.48% |
| 2 | Financials | 3.73% |
| 3 | Consumer Discretionary | 2.77% |
| 4 | Communication Services | 2.41% |
| 5 | Industrials | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5426
Hyliion Holdings
HYLN
$631M
| $26.4K | ﹤0.01% |
20,023
+6,015
| +43% | +$8.76K |
|
5427
MacroGenics
MGNX
$245M
| $25.6K | ﹤0.01% |
21,158
| – | – |
|
|
NB
5428
NioCorp Developments
NB
$587M
| $24.9K | ﹤0.01% |
+10,694
| New | +$26.7K |
|
5429
CALL
Prime Medicine
PRME
$558M
| $24.7K | ﹤0.01% |
10,000
| – | – |
|
5430
Precigen
PGEN
$1.97B
| $24.6K | ﹤0.01% |
17,324
-442
| -2% | -$628 |
|
|
MMA
5431
Alta Global Group
MMA
$12.5M
| $24.5K | ﹤0.01% |
21,687
+7,200
| +50% | +$6.74K |
|
|
USARW
5432
DELISTED
USA Rare Earth Inc Warrant
USARW
| $24.4K | ﹤0.01% |
+10,270
| New | +$21K |
|
5433
TRX Gold Corp
TRX
$259M
| $24.3K | ﹤0.01% |
72,532
+5,000
| +7% | +$1.6K |
|
5434
Outlook Therapeutics
OTLK
$169M
| $24.2K | ﹤0.01% |
15,127
| – | – |
|
5435
Neuraxis
NRXS
$81.5M
| $24.2K | ﹤0.01% |
+10,000
| New | +$23.4K |
|
5436
Outdoor Holding Co
POWW
$256M
| $23.9K | ﹤0.01% |
18,704
+4,695
| +34% | +$7.45K |
|
5437
Arbe Robotics
ARBE
$79.4M
| $23.7K | ﹤0.01% |
13,300
+1,500
| +13% | +$2.14K |
|
5438
Atossa Therapeutics
ATOS
$24.1M
| $23.1K | ﹤0.01% |
1,857
-13
| -0.7% | -$155 |
|
|
VXRT
5439
DELISTED
Vaxart
VXRT
| $22.6K | ﹤0.01% |
49,921
-11,034
| -18% | -$4.8K |
|
5440
CALL
Fate Therapeutics
FATE
$270M
| $22.4K | ﹤0.01% |
20,000
-10,000
| -33% | -$11.6K |
|
|
URG
5441
Ur-Energy
URG
$481M
| $22.3K | ﹤0.01% |
21,250
| – | – |
|
5442
Compugen
CGEN
$214M
| $22K | ﹤0.01% |
12,378
-1,000
| -7% | -$1.48K |
|
5443
CALL
Coherus Oncology
CHRS
$222M
| $21.9K | ﹤0.01% |
+30,000
| New | +$25.9K |
|
5444
Smart Sand
SND
$178M
| $21.9K | ﹤0.01% |
10,900
| – | – |
|
5445
Lineage Cell Therapeutics
LCTX
$267M
| $21.8K | ﹤0.01% |
24,074
-8,598
| -26% | -$5.1K |
|
5446
Milestone Pharmaceuticals
MIST
$133M
| $21.4K | ﹤0.01% |
11,050
-100,490
| -90% | -$134K |
|
5447
Standard BioTools
LAB
$311M
| $21.4K | ﹤0.01% |
+17,854
| New | +$19.8K |
|
|
5448
CALL
Precigen
PGEN
$1.97B
| $21.3K | ﹤0.01% |
+15,000
| New | +$21.3K |
|
5449
Veritone
VERI
$96.7M
| $21.3K | ﹤0.01% |
16,866
+1,372
| +9% | +$2.49K |
|
5450
Xilio Therapeutics
XLO
$60.2M
| $21.1K | ﹤0.01% |
+2,214
| New | +$23.4K |
|
Similar funds
LPL Financial's Q2 2025 Portfolio in Review
As of Q2 2025, LPL Financial held 5,729 positions worth $300B, up 17% from $257B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
LPL Financial deployed $20.8B of net new capital in Q2 2025, opening 391 new positions and adding to 3,438 existing holdings. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 4,689,747 shares worth $235M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.4% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $728M trimmed.
- LPL Financial's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 4,689,747 shares worth $235M.
- LPL Financial added most to Capital Group Dividend Value ETF in Q2 2025, an estimated $486M increase.
- LPL Financial's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $728M.
- LPL Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $31.5M.
- LPL Financial's ten largest holdings make up 15% of its $300B portfolio in Q2 2025.
- LPL Financial opened 391 new positions and closed 181 in Q2 2025.
- LPL Financial's portfolio value rose 17% quarter-over-quarter to $300B.
Based on LPL Financial's 13F filing for Q2 2025, filed 12 Aug 2025.